Urogen Pharma (NASDAQ:URGN – Get Free Report) is expected to be releasing its Q2 2026 results before the market opens on Thursday, August 6th. Urogen Pharma (NASDAQ:URGN – Get Free Report) last released its earnings results on Thursday, May 7th. On average, analysts expect Urogen Pharma to post $-1 EPS for the current fiscal year and $2 EPS for the next fiscal year. Get Urogen Pharma alerts:Urogen Pharma Price PerformanceUrogen Pharma stock opened at $40.45 on Thursday. Featured StoriesReceive News & Ratings for Urogen Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Urogen Pharma and related companies with MarketBeat.com's FREE daily email newsletter.